ChoriocarcinomaSymptoms, Doctors, Treatments, Advances & More
Learn About Choriocarcinoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Advocate Lutheran General Cancer Institute
Timothy Lestingi is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Lestingi is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Ureteroscopy, and Gastrostomy. Dr. Lestingi is board certified in American Board Of Internal Medicine, Medical Oncology.
Michael Seckl practices practicing medicine in London, United Kingdom. Mr. Seckl is rated as an Elite expert by MediFind in the treatment of Choriocarcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Gestational Trophoblastic Disease, Choriocarcinoma, Hydatidiform Mole, Hysterectomy, and Orchiectomy.
Sakhr Alshwayyat practices practicing medicine in Amman, Jordan. Alshwayyat is rated as an Elite expert by MediFind in the treatment of Choriocarcinoma. They are also highly rated in 3 other conditions, according to our data. Their clinical expertise encompasses Choriocarcinoma, Persistent Mullerian Duct Syndrome, Adenoid Cystic Carcinoma, Papillary Thyroid Cancer, and Thyroidectomy.
Summary: This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish...
Summary: A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.